Contemporary OB/GYN week in review: Maternal mortality, mifepristone, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: Maternal mortality, mifepristone, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, July 1 - Friday, July 5, 2024), and click each link to read and watch anything you may have missed.
1.) Issues and focus points for maternal mortality tracking
Inequities in maternal health, changes in maternal mortality tracking, and how methods from the CDC can lead to overestimations of maternal death.
Click here for the full article.
2.) The significance of the Supreme Court upholding mifepristone access
In an interview with Contemporary OB/GYN, Bianca Hall, DO, MSCR, discusses the Supreme Court’s decision affirming mifepristone's safety and accessibility, emphasizing its role in providing comprehensive abortion care.
Click here for the full article.
3.) Study finds telehealth medication abortion as effective as in-person care
A recent study reveals that medication abortions via telehealth with mailed medications are as effective and safe as traditional in-person care, offering a viable alternative for abortion services.
Click here for the full article.
4.) FDA grants fast track to 99mTc-maraciclatide for endometriosis diagnosis
Serac Healthcare’s 99mTc-maraciclatide, a new radio-labelled tracer, gains FDA Fast Track Designation for its potential to improve non-invasive diagnosis of superficial peritoneal endometriosis in patients aged 16 and older.
Click here for the full article.
5.) ED contraception may reduce unintended pregnancies
A recent study reveals that expanding pregnancy prevention services in emergency department care may address the high incidence of unintended pregnancies.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More
